English
Regional settings| Spread | 1.20 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ £5,000.00 Short position overnight fee ~ £4,000.00 | -0.025295% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ £5,000.00 Short position overnight fee ~ £4,000.00 | 0.003377% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | GBP | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | United Kingdom of Great Britain and Northern Ireland | ||||
| Commission on trade1 | 0% |
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 36.03 |
| Open | 36.01 |
| 1-Year Change | 34.47% |
| Day's Range | 35.83 - 36.43 |
Diploma PLC is engaged in supplying specialized products and services to a range of end segments in its three sectors of Controls, Seals and Life Sciences. The Controls Sector businesses supply specialized wiring, cable, connectors, fasteners, adhesives and control devices used in a range of technically demanding applications. The Seals Sector businesses supply a range of seals, gaskets, cylinders, components and kits used in heavy mobile machinery and specialized industrial equipment. The Life Sciences Sector businesses supply a range of consumables, instrumentation and related services to the healthcare and environmental industries. The Company's subsidiaries include HB Sealing Products, Inc., HB Sealing Products Limited, HB Sealing Products Limited, Clarendon Specialty Fasteners Limited, Clarendon Specialty Fasteners, Inc., IS-Rayfast Limited, Somagen Diagnostics Inc., AMT Electrosurgery Inc. and Vantage Endoscopy Inc., among others.
BRIEF: For the fiscal year ended 30 September 2021, Diploma PLC revenues increased 46% to £787.4M. Net income increased 42% to £69.8M. Revenues reflect Controls segment increase from £156.6M to £343.3M, Life Sciences segment increase of 29% to £180.4M, Seals segment increase of 9% to £263.7M, North America segment increase of 80% to £411.8M, Rest of Europe segment increase of 31% to £166.5M, Rest of World segment increase of 36% to £66.6M.
01/2008, Scrip Issue, 4 new share for every 1 shares held.
